Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis.

Ishaq M, Hu J, Wu X, Fu Q, Yang Y, Liu Q, Guo D.

Mol Biotechnol. 2008 Jul;39(3):231-8. doi: 10.1007/s12033-008-9040-0. Epub 2008 Feb 8.

PMID:
18259889
2.

Identification of host proteins required for HIV infection through a functional genomic screen.

Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ.

Science. 2008 Feb 15;319(5865):921-6. doi: 10.1126/science.1152725. Epub 2008 Jan 10.

3.

Identification of potential drug targets using genomics and proteomics: a systems approach.

Klase ZA, Van Duyne R, Kashanchi F.

Adv Pharmacol. 2008;56:327-68. Review. No abstract available.

PMID:
18086417
4.

HIV-1 drug-resistance and drug-dependence.

Baldwin C, Berkhout B.

Retrovirology. 2007 Oct 25;4:78. Review.

5.

Protein methylation is required to maintain optimal HIV-1 infectivity.

Willemsen NM, Hitchen EM, Bodetti TJ, Apolloni A, Warrilow D, Piller SC, Harrich D.

Retrovirology. 2006 Dec 15;3:92.

6.
7.

Role of RNA helicases in HIV-1 replication.

Jeang KT, Yedavalli V.

Nucleic Acids Res. 2006;34(15):4198-205. Epub 2006 Aug 25. Review.

8.

Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.

Agbottah E, Deng L, Dannenberg LO, Pumfery A, Kashanchi F.

Retrovirology. 2006 Aug 7;3:48.

9.

Viral and cellular RNA helicases as antiviral targets.

Kwong AD, Rao BG, Jeang KT.

Nat Rev Drug Discov. 2005 Oct;4(10):845-53. Review.

PMID:
16184083
10.

Therapeutic targets for HIV-1 infection in the host proteome.

Liang WS, Maddukuri A, Teslovich TM, de la Fuente C, Agbottah E, Dadgar S, Kehn K, Hautaniemi S, Pumfery A, Stephan DA, Kashanchi F.

Retrovirology. 2005 Mar 21;2:20.

11.

Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression.

Boulanger MC, Liang C, Russell RS, Lin R, Bedford MT, Wainberg MA, Richard S.

J Virol. 2005 Jan;79(1):124-31.

12.

Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.

Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT.

Cell. 2004 Oct 29;119(3):381-92.

13.

Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection.

Kibler KV, Miyazato A, Yedavalli VS, Dayton AI, Jacobs BL, Dapolito G, Kim SJ, Jeang KT.

J Biol Chem. 2004 Nov 19;279(47):49055-63. Epub 2004 Sep 14.

14.

DEAD-box proteins: the driving forces behind RNA metabolism.

Rocak S, Linder P.

Nat Rev Mol Cell Biol. 2004 Mar;5(3):232-41. Review. No abstract available.

PMID:
14991003
15.

A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.

Cocude C, Truong MJ, Billaut-Mulot O, Delsart V, Darcissac E, Capron A, Mouton Y, Bahr GM.

J Gen Virol. 2003 Dec;84(Pt 12):3215-25.

PMID:
14645903
16.

An integrated view of aromatase and its inhibition.

Miller WR, Anderson TJ, Evans DB, Krause A, Hampton G, Dixon JM.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):413-21. Review.

PMID:
14623539
18.

Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ("fat") nucleoside analogues.

Zhang N, Chen HM, Koch V, Schmitz H, Minczuk M, Stepien P, Fattom AI, Naso RB, Kalicharran K, Borowski P, Hosmane RS.

J Med Chem. 2003 Oct 23;46(22):4776-89.

PMID:
14561097
19.

Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.

Zhang N, Chen HM, Koch V, Schmitz H, Liao CL, Bretner M, Bhadti VS, Fattom AI, Naso RB, Hosmane RS, Borowski P.

J Med Chem. 2003 Sep 11;46(19):4149-64.

PMID:
12954067
20.

Adherence to HAART regimens.

Chesney M.

AIDS Patient Care STDS. 2003 Apr;17(4):169-77. Review.

PMID:
12737640

Supplemental Content

Support Center